Authors: Piot, O Gallois, H Baguet, JP Mallion, JM

Citation: O. Piot et al., First-line treatment of hypertension: from monotherapy to fixed low-dose combination therapy, J HUM HYPER, 15(7), 2001, pp. 443-446

Authors: Chamontin, B Lang, T Vaisse, B Nicodeme, R Antoine, MP Lazorthes, ML Gallois, H Poggi, L

Citation: B. Chamontin et al., Management of hypertension in France - Data issued from a survey conductedin the French regions, ARCH MAL C, 94(8), 2001, pp. 823-827

Authors: Chamontin, B Lang, T Vaisse, B Nicodeme, R Antoine, MP Lazorthes, ML Gallois, H Poggi, L

Citation: B. Chamontin et al., Hypertension and associated cardiovascular risk factors in diabetics: Results of the PHARE study carried out in general practice, ARCH MAL C, 94(8), 2001, pp. 869-873

Authors: Yaisse, B Silhol, F Bouchlagen, K Gallois, H Poggi, L

Citation: B. Yaisse et al., New requirements in the first-line treatment of arterial hypertension: whydo we need fixed very-low dose combination therapies, PRESSE MED, 28(9), 1999, pp. 500-506

Authors: Haiat, R Piot, O Gallois, H Hanania, G

Citation: R. Haiat et al., Blood pressure response to the first 36 hours of heart failure therapy with perindopril versus captopril, J CARDIO PH, 33(6), 1999, pp. 953-959

Authors: Gallois, H Piot, O

Citation: H. Gallois et O. Piot, Bradykinin and inhibition of angiotensin-converting enzyme in hypertension, N ENG J MED, 340(12), 1999, pp. 968-968